author-photo

Chih-Chin Liu

Merck & Co.

8

Papers

18

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Post-hoc analysis of long-term outcomes in patients with CR, PR, or SD to pembrolizumab (pembro) or platinum-based chemotherapy (chemo) as 1L therapy for advanced urothelial carcinoma (UC) in KEYNOTE-361.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Landmark analysis of overall survival (OS) by objective response (OR) in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post-hoc analysis of the randomized, phase III KEYNOTE-240 study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Ertugliflozin and Slope of Chronic eGFR: Prespecified Analyses from the Randomized VERTIS CV Trial

2021 Clinical Journal of The American Society of Nephrology
Show All
- Source
- Cite
- Save
Citations (2)
1011. Efficacy and Safety of Doravirine in Treatment-Naïve Adults ≥50 Years Old With HIV-1

2020 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Effect of pembrolizumab (pembro) on hepatitis B viral (HBV) load and aminotransferase (ALT) levels in patients (pts) with advanced hepatocellular carcinoma (aHCC) in KEYNOTE-224 and KEYNOTE-240.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Gradient of Risk and Associations with Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function: Observations from VERTIS CV.

2020 Circulation
Show All
- Source
- Cite
- Save
Citations (7)
Pembrolizumab for previously treated advanced anal squamous cell carcinoma: Pooled results from the KEYNOTE-028 and KEYNOTE-158 studies.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (8)